RVMD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $28,864,353.68

Revolution Medicines Insider Trading History Chart

Revolution Medicines Share Price & Price History

^$97.49

▲ +1.34 (1.39%)

As of 02/6/2026 05:00 PM ET

Days: 30 | 90 | 365

Revolution Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/7/2026	Jack Anders	CFO	Sell	10,000	$98.00	$980,000.00	108,065
1/7/2026	Margaret A. Horn	COO	Sell	75,000	$100.56	$7,542,000.00	141,053
12/16/2025	Jack Anders	CFO	Sell	3,104	$77.09	$239,287.36	108,065
12/16/2025	Margaret A. Horn	COO	Sell	4,847	$76.82	$372,346.54	141,053
12/16/2025	Mark A. Goldsmith	Insider	Sell	15,394	$76.82	$1,182,567.08	232,469
12/16/2025	Stephen Michael Kelsey	Insider	Sell	5,447	$76.82	$418,438.54	278,600
11/25/2025	Mark A. Goldsmith	Insider	Sell	60,000	$75.08	$4,504,800.00	247,863
11/18/2025	Mark A. Goldsmith	Insider	Sell	20,000	$70.38	$1,407,600.00	247,863
11/12/2025	Mark A. Goldsmith	Insider	Sell	20,000	$65.07	$1,301,400.00	247,863
11/7/2025	Mark A. Goldsmith	Insider	Sell	30,000	$60.31	$1,809,300.00	347,863
10/13/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$48.54	$1,213,500.00	284,047
9/16/2025	Jack Anders	CFO	Sell	2,320	$45.82	$106,302.40	110,994
9/16/2025	Lin Wei	Insider	Sell	2,160	$45.82	$98,971.20	88,339
9/16/2025	Margaret A. Horn	COO	Sell	4,775	$45.82	$218,790.50	145,900
9/16/2025	Mark A. Goldsmith	Insider	Sell	13,411	$45.82	$614,492.02	452,309
9/16/2025	Stephen Michael Kelsey	Insider	Sell	5,367	$45.82	$245,915.94	284,047
9/15/2025	Stephen Michael Kelsey	Insider	Sell	25,000	$45.97	$1,149,250.00	289,414
9/11/2025	Stephen Michael Kelsey	Insider	Sell	100,000	$44.08	$4,408,000.00	289,414
9/3/2025	Jack Anders	CFO	Sell	5,238	$40.17	$210,410.46	113,314
9/2/2025	Jack Anders	CFO	Sell	4,762	$40.02	$190,575.24	113,314
3/17/2025	Jack Anders	CFO	Sell	1,864	$39.04	$72,770.56	115,006
3/17/2025	Margaret A. Horn	COO	Sell	3,058	$39.04	$119,384.32	153,533
3/17/2025	Mark A. Goldsmith	Insider	Sell	11,738	$39.04	$458,251.52	441,564
12/16/2024	Jack Anders	CFO	Sell	2,635	$45.40	$119,629.00	96,470
12/16/2024	Margaret A. Horn	COO	Sell	4,329	$45.40	$196,536.60	127,991
12/16/2024	Mark A. Goldsmith	Insider	Sell	11,714	$45.40	$531,815.60	325,056
12/5/2024	Thilo Schroeder	Director	Buy	1,304,347	$46.00	$59,999,962.00	2,096,612
10/14/2024	Stephen Michael Kelsey	Insider	Sell	16,666	$49.49	$824,800.34	264,408
10/11/2024	Jack Anders	CFO	Sell	10,000	$50.30	$503,000.00	98,932
10/11/2024	Jeff Cislini	General Counsel	Sell	6,000	$50.17	$301,020.00	45,634
10/11/2024	Margaret A. Horn	COO	Sell	50,000	$50.34	$2,517,000.00	132,320
10/11/2024	Mark A. Goldsmith	Insider	Sell	30,000	$50.36	$1,510,800.00	300,170
10/8/2024	Barbara Weber	Director	Sell	5,200	$48.02	$249,704.00	13,065
10/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$44.93	$449,300.00	300,170
8/1/2024	Mark A. Goldsmith	Insider	Sell	10,000	$45.88	$458,800.00	311,885
7/15/2024	Stephen Michael Kelsey	Insider	Sell	16,667	$46.47	$774,515.49	269,073
7/12/2024	Mark A. Goldsmith	Insider	Sell	25,000	$45.05	$1,126,250.00	311,885
7/9/2024	Jeff Cislini	General Counsel	Sell	2,399	$40.83	$97,951.17	47,088
7/9/2024	Sushil Patel	Director	Sell	2,155	$44.00	$94,820.00	19,948
6/26/2024	Jeff Cislini	General Counsel	Sell	2,000	$38.47	$76,940.00	49,487
6/24/2024	Stephen Michael Kelsey	Insider	Sell	200	$39.00	$7,800.00	269,073
5/3/2024	Jack Anders	CFO	Sell	10,000	$40.03	$400,300.00	101,959
4/10/2024	Mark A. Goldsmith	Insider	Sell	7,500	$35.48	$266,100.00	452,879
4/10/2024	Sushil Patel	Director	Sell	2,155	$37.00	$79,735.00	15,700
3/27/2024	Jeff Cislini	General Counsel	Sell	1,500	$30.99	$46,485.00	54,374
3/18/2024	Jack Anders	CFO	Sell	1,261	$31.58	$39,822.38	101,959
3/18/2024	Jeff Cislini	General Counsel	Sell	1,252	$31.58	$39,538.16	55,874
3/18/2024	Margaret A. Horn	COO	Sell	2,914	$31.58	$92,024.12	139,553
3/18/2024	Stephen Michael Kelsey	Insider	Sell	2,123	$31.58	$67,044.34	270,909
1/22/2024	Jeff Cislini	General Counsel	Sell	1,500	$27.00	$40,500.00	36,126
1/8/2024	Stephen Michael Kelsey	Insider	Sell	3,337	$29.01	$96,806.37	221,632
12/27/2023	Stephen Michael Kelsey	Insider	Sell	33,334	$29.01	$967,019.34	238,299
12/18/2023	Jack Anders	CFO	Sell	1,775	$25.90	$45,972.50	76,416
12/18/2023	Jeff Cislini	General Counsel	Sell	1,229	$25.90	$31,831.10	37,284
12/18/2023	Margaret A. Horn	COO	Sell	2,993	$25.90	$77,518.70	101,467
12/18/2023	Mark A. Goldsmith	Insider	Sell	8,165	$25.90	$211,473.50	376,167
12/15/2023	Margaret A. Horn	COO	Sell	5,000	$26.64	$133,200.00	104,460
11/20/2023	Jeff Cislini	General Counsel	Sell	1,500	$21.70	$32,550.00	38,513
10/16/2023	Margaret A. Horn	COO	Sell	25,000	$33.95	$848,750.00	96,960
10/11/2023	Stephen Michael Kelsey	Insider	Sell	16,667	$29.05	$484,176.35	273,721
9/28/2023	Jeff Cislini	General Counsel	Sell	2,000	$28.20	$56,400.00	40,013
9/18/2023	Jack Anders	CFO	Sell	1,427	$31.31	$44,679.37	53,667
9/18/2023	Jeff Cislini	General Counsel	Sell	1,214	$31.31	$38,010.34	42,013
9/18/2023	Margaret A. Horn	COO	Sell	2,514	$31.31	$78,713.34	96,960
9/18/2023	Stephen Michael Kelsey	Insider	Sell	2,060	$31.31	$64,498.60	290,388
9/15/2023	Margaret A. Horn	COO	Sell	5,000	$32.08	$160,400.00	99,474
9/1/2023	Barbara Weber	Director	Sell	15,000	$35.07	$526,050.00	15,825
9/1/2023	Jack Anders	CFO	Sell	20,000	$35.05	$701,000.00	55,094
9/1/2023	Mark A. Goldsmith	Insider	Sell	30,000	$35.05	$1,051,500.00	357,386
8/31/2023	Margaret A. Horn	COO	Sell	10,000	$34.05	$340,500.00	99,474
8/15/2023	Margaret A. Horn	COO	Sell	5,000	$30.53	$152,650.00	99,474
8/1/2023	Stephen Michael Kelsey	Insider	Sell	16,666	$29.19	$486,480.54	309,114
7/31/2023	Jeff Cislini	General Counsel	Sell	1,500	$26.02	$39,030.00	43,227
6/20/2023	Jack Anders	CFO	Sell	1,249	$24.89	$31,087.61	55,094
6/20/2023	Jeff Cislini	General Counsel	Sell	1,239	$25.14	$31,148.46	44,727
6/20/2023	Stephen Michael Kelsey	Insider	Sell	2,102	$24.89	$52,318.78	325,780
3/17/2023	Jack Anders	CFO	Sell	665	$21.78	$14,483.70	55,233
3/17/2023	Margaret A. Horn	Insider	Sell	1,230	$21.78	$26,789.40	100,062
3/10/2023	Thilo Schroeder	Director	Buy	100,000	$20.46	$2,046,000.00	1,553,134
3/7/2023	Thilo Schroeder	Director	Buy	550,000	$22.00	$12,100,000.00	1,453,134

SEC Filings (Institutional Ownership Changes) for Revolution Medicines (NASDAQ:RVMD)

94.34% of Revolution Medicines stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Revolution Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/6/2026	Global Retirement Partners LLC	397	$32K	0.0%	+1,002.8%	0.000%
2/6/2026	Eagle Health Investments LP	115,900	$9.23M	2.0%	N/A	0.060%
2/6/2026	PSP Research LLC	6,872	$0.55M	0.5%	N/A	0.004%
2/6/2026	Atle Fund Management AB	90,184	$7.18M	2.3%	+5.7%	0.047%
2/6/2026	PNC Financial Services Group Inc.	10,066	$0.80M	0.0%	+1.3%	0.005%
2/6/2026	Handelsbanken Fonder AB	54,175	$4.32M	0.0%	-7.2%	0.028%
2/6/2026	Profund Advisors LLC	26,929	$2.15M	0.1%	-27.4%	0.014%
2/6/2026	ProShare Advisors LLC	8,539	$0.68M	0.0%	+28.2%	0.004%
2/6/2026	HighTower Advisors LLC	2,749	$0.22M	0.0%	N/A	0.001%
2/5/2026	North Dakota State Investment Board	6,092	$0.49M	0.0%	N/A	0.003%
2/5/2026	S&CO Inc.	34,171	$2.72M	0.2%	+54.1%	0.018%
2/5/2026	Bessemer Group Inc.	117,662	$9.37M	0.0%	-51.8%	0.061%
2/5/2026	AIHC Capital Management Ltd	900,392	$71.72M	67.2%	N/A	0.466%
2/5/2026	New York Life Investment Management LLC	15,700	$1.25M	0.0%	-12.3%	0.008%
2/5/2026	Baader Bank Aktiengesellschaft	4,000	$0.32M	0.0%	N/A	0.002%
2/5/2026	Allworth Financial LP	577	$46K	0.0%	+57.2%	0.000%
2/4/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	3,900	$0.31M	0.0%	N/A	0.002%
2/4/2026	Centric Wealth Management	3,416	$0.27M	0.1%	N/A	0.002%
2/4/2026	Swiss Life Asset Management Ltd	6,723	$0.54M	0.0%	+7.1%	0.003%
2/2/2026	Danske Bank A S	3,100	$0.25M	0.0%	+47.6%	0.002%
1/30/2026	Jennison Associates LLC	305,260	$24.31M	0.0%	N/A	0.158%
1/30/2026	State of New Jersey Common Pension Fund D	50,085	$3.99M	0.0%	-14.1%	0.026%
1/30/2026	Torren Management LLC	416	$33K	0.0%	N/A	0.000%
1/30/2026	M&T Bank Corp	8,060	$0.64M	0.0%	N/A	0.004%
1/29/2026	Comerica Bank	23,285	$1.86M	0.0%	-95.3%	0.012%
1/29/2026	Pictet Asset Management Holding SA	1,137,121	$90.65M	0.1%	-13.3%	0.588%
1/29/2026	UBS Group AG	3,087,937	$245.95M	0.0%	+183.6%	1.597%
1/29/2026	Vanguard Group Inc.	16,719,886	$1.33B	0.0%	+6.7%	8.649%
1/29/2026	Calamos Advisors LLC	12,460	$0.99M	0.0%	N/A	0.006%
1/29/2026	China Universal Asset Management Co. Ltd.	34,001	$2.71M	0.2%	-20.5%	0.018%
1/28/2026	Arizona State Retirement System	39,161	$3.12M	0.0%	-5.2%	0.020%
1/28/2026	B. Metzler seel. Sohn & Co. AG	17,440	$1.39M	0.0%	-32.5%	0.009%
1/28/2026	West Michigan Advisors LLC	7,604	$0.61M	0.1%	N/A	0.004%
1/28/2026	M&T Bank Corp	661,929	$52.72M	0.2%	N/A	0.342%
1/28/2026	Universal Beteiligungs und Servicegesellschaft mbH	65,627	$5.23M	0.0%	-16.6%	0.034%
1/27/2026	Mass General Brigham Inc	344,091	$27.41M	3.4%	N/A	0.178%
1/27/2026	Zurcher Kantonalbank Zurich Cantonalbank	45,517	$3.63M	0.0%	+8.9%	0.024%
1/27/2026	GF Fund Management CO. LTD.	3,798	$0.30M	0.0%	-5.6%	0.002%
1/26/2026	JGP Global Gestao de Recursos Ltda.	2,545	$0.20M	0.1%	N/A	0.001%
1/26/2026	Mirae Asset Global Investments Co. Ltd.	21,289	$1.70M	0.0%	+194.6%	0.011%
1/26/2026	CWM LLC	702	$56K	0.0%	+51.6%	0.000%
1/23/2026	Farther Finance Advisors LLC	751	$60K	0.0%	+44.7%	0.000%
1/23/2026	Baillie Gifford & Co.	194,959	$15.53M	0.0%	N/A	0.101%
1/23/2026	Sumitomo Mitsui Trust Group Inc.	5,498	$0.44M	0.0%	N/A	0.003%
1/22/2026	Darwin Wealth Management LLC	500	$40K	0.0%	N/A	0.000%
1/21/2026	Yousif Capital Management LLC	1,994	$0.16M	0.0%	N/A	0.001%
1/21/2026	Indiana Trust & Investment Management Co	400	$32K	0.0%	N/A	0.000%
1/20/2026	Signaturefd LLC	656	$52K	0.0%	+33.1%	0.000%
1/20/2026	Harbor Capital Advisors Inc.	21,076	$1.68M	0.1%	-2.4%	0.011%
1/16/2026	Aberdeen Group plc	113,268	$9.02M	0.0%	N/A	0.059%
1/16/2026	Tema Etfs LLC	100,603	$8.01M	0.6%	-20.7%	0.052%
1/15/2026	J. Safra Sarasin Holding AG	7,766	$0.62M	0.0%	N/A	0.004%
1/12/2026	Avanza Fonder AB	3,036	$0.24M	0.0%	-30.0%	0.002%
1/9/2026	SG Americas Securities LLC	16,723	$1.33M	0.0%	+56.1%	0.009%
1/8/2026	Wealth Enhancement Advisory Services LLC	2,604	$0.21M	0.0%	N/A	0.001%
1/6/2026	Avior Wealth Management LLC	7,325	$0.58M	0.0%	-13.8%	0.004%
1/5/2026	GAMMA Investing LLC	1,339	$0.11M	0.0%	+60.0%	0.001%
12/15/2025	FNY Investment Advisers LLC	2,365	$0.11M	0.0%	N/A	0.001%
12/2/2025	Swiss Life Asset Management Ltd	6,280	$0.29M	0.0%	N/A	0.003%
11/19/2025	Danske Bank A S	2,100	$98K	0.0%	N/A	0.001%
11/17/2025	Woodline Partners LP	2,915,883	$136.17M	0.6%	+0.0%	1.508%
11/17/2025	TCG Crossover Management LLC	436,473	$20.38M	1.0%	N/A	0.226%
11/17/2025	Sender Co & Partners Inc.	8,637	$0.40M	0.0%	N/A	0.004%
11/17/2025	Verition Fund Management LLC	135,449	$6.33M	0.0%	-5.8%	0.070%
11/17/2025	Vestal Point Capital LP	630,000	$29.42M	1.3%	-47.5%	0.326%
11/17/2025	Polar Capital Holdings Plc	478,105	$22.33M	0.1%	-36.4%	0.247%
11/17/2025	Prelude Capital Management LLC	20,000	$0.93M	0.1%	N/A	0.010%
11/17/2025	Public Employees Retirement System of Ohio	54,143	$2.53M	0.0%	+0.6%	0.028%
11/17/2025	Paradigm Biocapital Advisors LP	6,223,291	$290.63M	8.3%	+2.1%	3.219%
11/17/2025	Mercer Global Advisors Inc. ADV	6,002	$0.28M	0.0%	N/A	0.003%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	9,196	$0.42M	0.0%	+23.1%	0.005%
11/17/2025	HighVista Strategies LLC	175,448	$8.19M	2.0%	+157.8%	0.091%
11/17/2025	Holocene Advisors LP	3,437,283	$160.52M	0.4%	-5.4%	1.778%
11/17/2025	Gotham Asset Management LLC	99,114	$4.63M	0.0%	N/A	0.051%
11/17/2025	Granahan Investment Management LLC	118,692	$5.54M	0.2%	-2.5%	0.061%
11/17/2025	Farallon Capital Management LLC	14,625,692	$683.02M	2.8%	+2.1%	7.566%
11/17/2025	Decheng Capital LLC	210,000	$9.81M	1.7%	-7.1%	0.109%
11/17/2025	Boxer Capital Management LLC	400,000	$18.68M	6.0%	-49.6%	0.207%
11/17/2025	Brevan Howard Capital Management LP	31,163	$1.46M	0.0%	-84.7%	0.016%
11/17/2025	Casdin Capital LLC	2,647,333	$123.63M	10.3%	-8.3%	1.369%
11/17/2025	Checkpoint Capital L.P.	492,300	$22.99M	7.7%	+75.8%	0.255%
11/17/2025	Baker BROS. Advisors LP	9,455,357	$441.57M	3.2%	+1.0%	4.891%
11/17/2025	California Public Employees Retirement System	230,974	$10.79M	0.0%	+7.7%	0.119%
11/17/2025	Bank of America Corp DE	753,867	$35.21M	0.0%	+30.7%	0.390%
11/17/2025	Aquatic Capital Management LLC	46,565	$2.18M	0.0%	-29.1%	0.024%
11/17/2025	Algert Global LLC	166,315	$7.77M	0.1%	+141.1%	0.086%
11/17/2025	Alliancebernstein L.P.	62,131	$2.90M	0.0%	+3.5%	0.032%
11/17/2025	Ameriprise Financial Inc.	1,224,759	$57.20M	0.0%	-8.9%	0.634%
11/14/2025	Schonfeld Strategic Advisors LLC	34,575	$1.62M	0.0%	+165.5%	0.018%
11/14/2025	Creative Planning	38,938	$1.82M	0.0%	-40.7%	0.020%
11/14/2025	Raymond James Financial Inc.	278,160	$12.99M	0.0%	-5.8%	0.144%
11/14/2025	Bellevue Group AG	5,573,838	$260.30M	5.4%	+21.7%	2.883%
11/14/2025	Caligan Partners LP	1,064,249	$49.70M	6.5%	+67.1%	0.551%
11/14/2025	Caisse de depot et placement du Quebec	108,400	$5.06M	0.0%	N/A	0.056%
11/14/2025	Deerfield Management Company L.P.	3,650,342	$170.47M	2.6%	+7.9%	1.888%
11/14/2025	Man Group plc	5,994	$0.28M	0.0%	-75.2%	0.003%
11/14/2025	ADAR1 Capital Management LLC	139,136	$6.50M	0.6%	+3.7%	0.072%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	41,801	$1.95M	0.0%	+10.2%	0.022%
11/14/2025	Acuta Capital Partners LLC	8,411	$0.39M	0.4%	-84.9%	0.004%
11/14/2025	Shay Capital LLC	46,000	$2.15M	0.2%	N/A	0.024%

Data available starting January 2016

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Today's Range

Now: $97.49

$96.43

$99.58

50 Day Range

MA: $92.12

$75.31

$123.27

52 Week Range

Now: $97.49

$29.17

$124.49

Volume

2,135,161 shs

Average Volume

5,016,000 shs

Market Capitalization

$18.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Revolution Medicines?: Revolution Medicines' top insider shareholders include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Lin Wei (Insider)
Jeff Cislini (General Counsel)
Sushil Patel (Director)
Barbara Weber (Director)
Learn More about top insider investors at Revolution Medicines.
Who are the major institutional investors of Revolution Medicines?: Revolution Medicines' top institutional investors include:
Vanguard Group Inc. — 8.65%
UBS Group AG — 1.60%
Pictet Asset Management Holding SA — 0.59%
AIHC Capital Management Ltd — 0.47%
M&T Bank Corp — 0.34%
Mass General Brigham Inc — 0.18%
Learn More about top institutional investors of Revolution Medicines stock.
Which institutional investors are selling Revolution Medicines stock?: Within the last quarter, RVMD stock was sold by these institutional investors:
Comerica Bank
Pictet Asset Management Holding SA
Bessemer Group Inc.
Tema Etfs LLC
Universal Beteiligungs und Servicegesellschaft mbH
Profund Advisors LLC
China Universal Asset Management Co. Ltd.
B. Metzler seel. Sohn & Co. AG
In the last year, company insiders that have sold Revolution Medicines company stock include:
Thilo Schroeder (Director)
Mark A Goldsmith (Insider)
Stephen Michael Kelsey (Insider)
Margaret A Horn (COO)
Jack Anders (CFO)
Learn More investors selling Revolution Medicines stock.
Which institutional investors are buying Revolution Medicines stock?: In the last quarter, RVMD stock was purchased by institutional investors including:
UBS Group AG
Vanguard Group Inc.
AIHC Capital Management Ltd
M&T Bank Corp
Mass General Brigham Inc
Jennison Associates LLC
Baillie Gifford & Co.
Aberdeen Group plc